These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23601006)

  • 1. Inhibitors in haemophilia B: the Italian experience.
    Castaman G; Bonetti E; Messina M; Morfini M; Rocino A; Scaraggi FA; Tagariello G;
    Haemophilia; 2013 Sep; 19(5):686-90. PubMed ID: 23601006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor.
    Holstein K; Schneppenheim R; Schrum J; Bokemeyer C; Langer F
    Hamostaseologie; 2014; 34 Suppl 1():S5-8. PubMed ID: 25382771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
    Chitlur M; Warrier I; Rajpurkar M; Lusher JM
    Haemophilia; 2009 Sep; 15(5):1027-31. PubMed ID: 19515028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of anaphylactic shock in haemophilia B patients with inhibitors.
    Warrier I; Lusher JM
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S125-8. PubMed ID: 9819043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
    Parquet A; Laurian Y; Rothschild C; Navarro R; Guérois C; Gay V; Durin A; Peynet J; Sultan Y
    Thromb Haemost; 1999 Oct; 82(4):1247-9. PubMed ID: 10544907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor development in haemophilia B: an orphan disease in need of attention.
    DiMichele D
    Br J Haematol; 2007 Aug; 138(3):305-15. PubMed ID: 17614818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis.
    Alexander S; Hopewell S; Hunter S; Chouksey A
    J Pediatr Hematol Oncol; 2008 Jan; 30(1):93-5. PubMed ID: 18176193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor IX antibody and immune tolerance.
    Warrier I
    Vox Sang; 1999; 77 Suppl 1():70-1. PubMed ID: 10529693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
    Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W;
    Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China.
    Dou X; Zhang W; Poon MC; Zhang X; Wu R; Feng X; Yang L; Cheng P; Chen S; Wang Y; Zhou H; Huang M; Song Y; Jin C; Zhang D; Chen L; Liu W; Zhang L; Xue F; Yang R
    Haemophilia; 2023 Jan; 29(1):123-134. PubMed ID: 36163649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune tolerance in haemophilia: the long journey to the fork in the road.
    DiMichele DM
    Br J Haematol; 2012 Oct; 159(2):123-34. PubMed ID: 22924753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with inhibitor development in Chinese patients with haemophilia B.
    Zhou J; Ding Q; Chen Z; Yang H; Lin L; Wang H; Wang X; Wu R
    Haemophilia; 2015 Jul; 21(4):e286-93. PubMed ID: 25929987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B.
    Recht M; Pollmann H; Tagliaferri A; Musso R; Janco R; Neuman WR
    Haemophilia; 2011 May; 17(3):494-9. PubMed ID: 21518148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.
    Windyga J; Lissitchkov T; Stasyshyn O; Mamonov V; Ghandehari H; Chapman M; Fritsch S; Wong WY; Pavlova BG; Abbuehl BE
    Haemophilia; 2014 Sep; 20(5):651-8. PubMed ID: 24697870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor.
    Klarmann D; Martinez Saguer I; Funk MB; Knoefler R; von Hentig N; Heller C; Kreuz W
    Haemophilia; 2008 Jan; 14(1):44-9. PubMed ID: 18081836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.
    Boylan B; Rice AS; Neff AT; Manco-Johnson MJ; Kempton CL; Miller CH;
    J Thromb Haemost; 2016 Oct; 14(10):1931-1940. PubMed ID: 27501440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.
    Thorland EC; Drost JB; Lusher JM; Warrier I; Shapiro A; Koerper MA; Dimichele D; Westman J; Key NS; Sommer SS
    Haemophilia; 1999 Mar; 5(2):101-5. PubMed ID: 10215957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure.
    Barnes C; Rudzki Z; Ekert H
    Haemophilia; 2000 Nov; 6(6):693-5. PubMed ID: 11122398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review.
    Bon A; Morfini M; Dini A; Mori F; Barni S; Gianluca S; de Martino M; Novembre E
    Ital J Pediatr; 2015 Feb; 41():12. PubMed ID: 25887512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of inhibitor antibodies in the Canadian haemophilia population.
    Webert KE; Rivard GE; Teitel J; Carcao M; Lillicrap D; St-Louis J; Walker IR
    Haemophilia; 2012 May; 18(3):e254-9. PubMed ID: 22077390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.